01 1Natco Pharma
01 1IBANDRONATE SODIUM MONOHYDRATE (INJECTABLE GRADE)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-10
Pay. Date : 2013-07-23
DMF Number : 24824
Submission : 2011-05-31
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IBANDRONATE SODIUM MONOHYDRATE (INJECTABLE GRADE), with a corresponding US DMF Number 24824.
Remarkably, this DMF maintains an Active status since its submission on May 31, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 10, 2013, and payment made on July 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
